GlassScriptPhysician profile
Joseph J Germano
NPI 1861445926
$28,934.88
in general payments reported to CMS, 2019-2025
22 companies · $3,772 in 2025
The $3,772 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,179 · 2020: $2,758 · 2021: $3,764 · 2022: $5,658 · 2023: $4,087 · 2024: $3,716 · 2025: $3,772.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Travel and Lodging: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,579.35 |
| Travel and Lodging | $995.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,694.39 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $7,463.99 | 2019-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Rivacor 7 Dr-T |
| Abbott Laboratories | $2,872.47 | 2019-2025 | Amplatzer Amulet, Aveir, Cardiomems |
| Medtronic Vascular, INC. | $2,543.49 | 2019-2020 | |
| Biosense Webster, INC. | $1,877.76 | 2019-2025 | Qdot Micro Catheter, Qdot Micro, Octaray Mapping Catheter |
| Boston Scientific Corporation | $1,790.26 | 2019-2025 | Watchman Flx, General - Therapies, Emblem Mri S-Icd |
| Medical Device Business Services, INC. | $1,482.77 | 2019-2024 | Carto 3 |
| Impulse Dynamics (USA) INC. | $339.11 | 2021-2024 | Optimizer |
| Cardiva Medical, INC. | $167.34 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Janssen Pharmaceuticals, INC | $136.26 | 2019 | |
| Pfizer INC. | $109.93 | 2022-2023 | |
| Cordis US Corp. | $100.86 | 2024-2025 | Mynx Control Venous, Mynx Venous Vcd |
| Philips North America LLC | $87.45 | 2021 | |
| Stryker Corporation | $57.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $53.63 | 2022-2023 | Lifevest |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $44.84 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $33.55 | 2024 | Uptravi, Opsumit |
| Heartflow, INC. | $25.72 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $23.72 | 2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $19.40 | 2023 | |
| Cvrx, INC. | $10.94 | 2024 | Barostim Neo System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Germano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.